Hexarelin Protects Newborn Brain From Injury Through Akt/GSK-3β Survival Signaling
The GH secretagogue hexarelin reduced neonatal brain injury and activated Akt/GSK-3β neuroprotective signaling pathways, demonstrating direct neuroprotection independent of GH release for birth-related brain damage.
Quick Facts
What This Study Found
Hexarelin reduced neonatal brain injury in a hypoxia-ischemia model and altered Akt/GSK-3β phosphorylation — activating pro-survival signaling cascades for direct GH-independent neuroprotection in the developing brain.
Key Numbers
How They Did This
animal-study study on ghrp, neuroprotection.
Why This Research Matters
Relevant for ghrp, neuroprotection, receptor-signaling.
The Bigger Picture
Advances peptide research with translational implications.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Hexarelin reduced neonatal brain injury in a hypoxia-ischemia model and altered Akt/GSK-3β phosphorylation — activating pro-survival signaling cascade
- Evidence Grade:
- preliminary evidence.
- Study Age:
- Published in 2005.
- Original Title:
- Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.
- Published In:
- Endocrinology, 146(11), 4665-72 (2005)
- Authors:
- Brywe, Katarina G, Leverin, Anna-Lena, Gustavsson, Malin, Mallard, Carina, Granata, Riccarda, Destefanis, Silvia, Volante, Marco, Hagberg, Henrik, Ghigo, Ezio, Isgaard, Jörgen
- Database ID:
- RPEP-01018
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What was studied?
Hexarelin Protects Newborn Brain From Injury Through Akt/GSK-3β Survival Signaling
What was found?
The GH secretagogue hexarelin reduced neonatal brain injury and activated Akt/GSK-3β neuroprotective signaling pathways, demonstrating direct neuroprotection independent of GH release for birth-related brain damage.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01018APA
Brywe, Katarina G; Leverin, Anna-Lena; Gustavsson, Malin; Mallard, Carina; Granata, Riccarda; Destefanis, Silvia; Volante, Marco; Hagberg, Henrik; Ghigo, Ezio; Isgaard, Jörgen. (2005). Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.. Endocrinology, 146(11), 4665-72.
MLA
Brywe, Katarina G, et al. "Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.." Endocrinology, 2005.
RethinkPeptides
RethinkPeptides Research Database. "Growth hormone-releasing peptide hexarelin reduces neonatal ..." RPEP-01018. Retrieved from https://rethinkpeptides.com/research/brywe-2005-growth-hormonereleasing-peptide-hexarelin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.